[DISCLOSURE]
Crystal Genomics (083790) announced on June 14 that it has signed an exclusive global option and license contract worth US$125 million with Canada’s Aptose Biosciences for the development of CG026806 in China.
By Hwang You-mee (
glamazon@heraldcorp.com)